Renaissance Technologies
AXLA

Renaissance Technologies’s Axcella Health Inc. Common Stock AXLA Stock Holding History

Renaissance Technologies’s Portfolio AXLA Stock Details AXLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-520
Closed -$3K – 4270
2023
Q2 		$3K Sell
520
-372
-42% -$3.49K ﹤0.01% 3860
2023
Q1 		$11K Sell
892
-876
-50% -$11.7K ﹤0.01% 3884
2022
Q4 		$14K Sell
1,768
-384
-18% -$9.95K ﹤0.01% 4015
2022
Q3 		$92K Sell
2,152
-76
-3% -$4.04K ﹤0.01% 3622
2022
Q2 		$113K Buy
2,228
+272
+14% +$13.4K ﹤0.01% 3819
2022
Q1 		$126K Buy
1,956
+92
+5% +$4.59K ﹤0.01% 3755
2021
Q4 		$97K Sell
1,864
-147
-7% -$10.3K ﹤0.01% 3685
2021
Q3 		$150K Sell
2,011
-4,317
-68% -$370K ﹤0.01% 3260
2021
Q2 		$634K Buy
6,328
+3,565
+129% +$353K ﹤0.01% 2868
2021
Q1 		$329K Buy
2,763
+411
+17% +$58K ﹤0.01% 3033
2020
Q4 		$305K Buy
2,352
+96
+4% +$12.3K ﹤0.01% 3028
2020
Q3 		$261K Sell
2,256
-4,896
-68% -$603K ﹤0.01% 3040
2020
Q2 		$989K Buy
+7,152
New +$875K ﹤0.01% 2545

Other funds holding AXLA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies's AXLA Position: Q3 2023 in Review

Renaissance Technologies sold out of Axcella Health Inc. Common Stock (AXLA) in Q3 2023, closing a stake of 520 shares — an estimated $3K sold.

Renaissance Technologies first reported a position in AXLA in Q2 2020 and held it in 13 quarters. The position peaked at $989K in Q2 2020. 15 funds tracked by Wall St. Rank hold AXLA as of Q3 2023.

  • Renaissance Technologies reported no remaining Axcella Health Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Renaissance Technologies sold 520 Axcella Health Inc. Common Stock shares in Q3 2023, an estimated $3K.
  • Renaissance Technologies first reported a position in Axcella Health Inc. Common Stock in Q2 2020 and held it in 13 quarters.
  • Renaissance Technologies's Axcella Health Inc. Common Stock position peaked at $989K in Q2 2020.
  • 15 funds tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.